OSUR · Orasure Technologies Inc
$3.87
-0.09 (-2.27%)
At close · Jul 17
Market Cap
$266.44M
Shares
68.85M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Carrie Eglinton Manner | CEO | $4,292,228 |
| Kathleen Weber | President of Molecular Solutions | $1,836,435 |
| Kenneth McGrath | CFO | $1,316,208 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Carrie Eglinton Manner | CEO | $5,602,298 |
| Ken McGrath | CFO | $1,683,370 |
| Kenneth McGrath | CFO | $1,683,370 |
| Kathleen Weber | President of Molecular Solutions | $1,397,738 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Carrie Eglinton Manner | CEO | $6,701,767 |
| Kathleen Weber | President of Molecular Solutions | $1,680,331 |
| Kenneth McGrath | CFO | $1,528,599 |
| Ken McGrath | CFO | $1,528,599 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Carrie Eglinton Manner | CEO | $6,746,923 |
| Stephen Tang | CEO | $2,769,508 |
| Agnieszka Gallagher | General Counsel | $1,830,067 |
| Lisa Nibauer | President of Diagnostics | $1,729,339 |
| Kathleen Weber | President of Molecular Solutions | $1,676,198 |
| Scott Gleason | CFO | $1,197,246 |
| Nancy Gagliano | CEO | $940,292 |
| Ken McGrath | CFO | $838,808 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Stephen Tang | CEO | $2,959,781 |
| Kathleen Weber | President of Molecular Solutions | $1,551,445 |
| Jack E. Jerrett | Former Senior Vice President, General Counsel and Chief Compliance Officer | $1,452,144 |
| Agnieszka Gallagher | General Counsel | $1,267,465 |
| Lisa Nibauer | President of Diagnostics | $1,187,555 |
| Scott Gleason | CFO | $787,543 |
| Roberto Cuca | CFO | $385,476 |
| Ken McGrath | CFO | — |
| Nancy Gagliano | CEO | — |
| Carrie Eglinton Manner | CEO | — |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Stephen Tang | CEO | $3,085,421 |
| Anthony Zezzo | Former Executive Vice President, Business Unit Leader, Infectious Disease | $2,400,718 |
| Kathleen Weber | President of Molecular Solutions | $1,709,953 |
| Former Chief | Financial Officer | $1,623,613 |
| Roberto Cuca | CFO | $1,623,613 |
| Former Senior Vice | General Counsel | $1,219,993 |
| Jack E. Jerrett | General Counsel | $1,219,993 |
| Lisa Nibauer | President of Diagnostics | $1,054,849 |
| Scott Gleason | CFO | — |
| Carrie Eglinton Manner | CEO | — |
| Agnieszka Gallagher | General Counsel | — |
| Interim CFO | Senior Vice President, | — |
| Nancy Gagliano | CEO | — |
| Ken McGrath | CFO | — |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Stephen Tang | CEO | $2,114,821 |
| Roberto Cuca | CFO | $1,201,703 |
| Former Chief | Financial Officer | $1,201,703 |
| Kathleen Weber | President of Molecular Solutions | $1,124,085 |
| Anthony Zezzo | Former Executive Vice President, Business Unit Leader, Infectious Disease | $1,004,738 |
| Anthony Zezzo II | Executive Vice President, Business Unit Leader, Infectious Disease | $1,004,738 |
| Former Senior Vice | General Counsel | $958,265 |
| Jack E. Jerrett | General Counsel | $958,265 |
| Agnieszka Gallagher | General Counsel | — |
| Lisa Nibauer | President of Diagnostics | — |
| Corporate Communications | & | — |
Fiscal 2018
| Executive | Role | Total |
|---|---|---|
| Stephen Tang | CEO | $2,099,594 |
| Anthony Zezzo II | Executive Vice President, Business Unit Leader, Infectious Disease | $1,060,913 |
| Anthony Zezzo | Former Executive Vice President, Business Unit Leader, Infectious Disease | $1,060,913 |
| Roberto Cuca | CFO | $1,052,703 |
| Jack E. Jerrett | General Counsel | $973,462 |
| Kathleen Weber | President of Molecular Solutions | $896,148 |
| Lisa Nibauer | President of Diagnostics | — |
Fiscal 2017
| Executive | Role | Total |
|---|---|---|
| Anthony Zezzo II | Executive Vice President, Business Unit Leader, Infectious Disease | $1,064,365 |
| Jack E. Jerrett | General Counsel | $920,128 |
| Kathleen Weber | President of Molecular Solutions | $865,165 |